Clémentine Le Magnen

9PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersCancer cell biologySolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 22, 2026
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

|Jun 12, 2026
A Fully Human Engineered Bone Niche With Endogenous Osteoclastogenesis Reveals Osteoclast-Dependent Osteomimicry in Prostate Cancer Cells.

|Jan 26, 2025
p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment.

Darya Yanushko, Beatriz German Falcon, Rana El Bizri

|Mar 07, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer research.

W Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna

|Jan 11, 2024
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.

Ivana Bratic Hench, Luca Roma, Floriana Conticelli

|Nov 03, 2023
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.

Michele Garioni, Viviane J Tschan, Lauriane Blukacz

Pageof 2

Frequent Collaborators

2 joint publications

Robin Dolgos

2 joint publications

Mitchell G Lawrence

2 joint publications

Renea A Taylor

2 joint publications

Cyrill Rentsch